AviChina Industry & Technology Company Limited (2357.HK) Bundle
AviChina's mid‑2025 financial snapshot packs immediate implications for investors: first‑half revenue rose to RMB 37,465 million (+11.43% year‑over‑year) and TTM revenue reached RMB 90,815 million (+17.18% YoY), yet gross profit margin fell to 20.22% from 23.93% a year earlier while gross profit dipped to RMB 7,576 million, signaling margin pressure despite top‑line growth; profitability shows strain with net profit attributable to owners at RMB 1,030 million (a 17.67% decline) and a net profit margin of 2.75%, EPS (TTM) at RMB 0.129, and a forecasted ROE of 7.5% in three years; the balance sheet reports total assets of RMB 199.53 billion, total liabilities of RMB 101.79 billion and total equity of RMB 97.74 billion (debt‑to‑equity ~1.04), cash and cash equivalents of RMB 30,390 million, a gearing uptick to 9.62%, and increased R&D spending to RMB 2,170 million; liquidity signals include a net cash change of RMB ‑4.48 billion in 1H2025 but free cash flow of RMB 662.02 million (+223.36% YoY); valuation metrics show a TTM P/E of 14.28, forward P/E 12.16, P/S 0.31, P/B 0.29 and dividend yield of 2.09%, while strategic pivots into the low‑altitude economy, helicopter competitiveness, digital and green transformation present clear growth levers amid risks from margin compression, higher leverage and cash flow variability-read on to explore how these numbers translate into investment decision points
AviChina Industry & Technology Company Limited (2357.HK) - Revenue Analysis
AviChina reported solid top-line expansion in H1 2025 but faced margin pressure. Revenue drivers remain concentrated in aviation systems while strategic moves target the low-altitude economy and helicopter competitiveness.- H1 2025 revenue: RMB 37,465 million (+11.43% YoY vs H1 2024).
- TTM revenue as of 30 Jun 2025: RMB 90,815 million (+17.18% YoY).
- 2024 Aviation Ancillary System & Related Business contribution: ~64% of total revenue (RMB 56,000 million).
- H1 2025 gross profit margin: 20.22% (down from 23.93% in H1 2024).
- TTM cost of sales (ending 30 Jun 2025): RMB 72,965 million - ~79% of TTM revenue.
- Strategic focus: expanding low-altitude economy presence and enhancing helicopter competitiveness.
| Metric | H1 2024 | H1 2025 | TTM Jun 30, 2024 | TTM Jun 30, 2025 |
|---|---|---|---|---|
| Revenue (RMB million) | 33,617 (implied) | 37,465 | 77,496 (implied) | 90,815 |
| YoY Revenue Growth | - | +11.43% | - | +17.18% |
| Gross Profit Margin | 23.93% | 20.22% | - | - |
| Cost of Sales (RMB million) | - | - | - | 72,965 |
| Cost of Sales / Revenue | - | - | - | 79% |
| Major segment revenue (2024) | Aviation Ancillary System & Related Business: RMB 56,000 (≈64% of total) | |||
- Top-line growth is healthy (TTM +17.18%) but margin compression (H1 gross margin -371 bps YoY) warrants scrutiny of cost trends and pricing.
- High concentration in Aviation Ancillary System (~64%) implies revenue sensitivity to civil aviation cycle and defense procurement shifts.
- Cost of sales consuming ~79% of revenue on a TTM basis leaves limited gross-profit buffer; operational efficiencies or higher-margin product mix will be critical.
- Expansion into low-altitude economy and helicopter capabilities could diversify revenue and improve margins over medium term if execution and market demand align.
AviChina Industry & Technology Company Limited (2357.HK) - Profitability Metrics
AviChina Industry & Technology Company Limited (2357.HK) reported a deterioration in core profitability in the first half of 2025, driven by a shift in revenue mix and compressed gross margins.- Net profit attributable to owners: RMB 1,030 million in H1 2025, down 17.67% YoY from H1 2024.
- Gross profit: RMB 7,576 million in H1 2025, a decrease of 5.85% YoY.
- Net profit margin: 2.75% in H1 2025, versus 3.73% in H1 2024.
- EPS (TTM to 30 Jun 2025): RMB 0.129, versus RMB 0.157 for the same trailing period in 2024.
- Short-to-medium term outlook: ROE forecast ~7.5% in three years, implying potential improvement from current levels if margins and mix recover.
| Metric | H1 2025 | H1 2024 | Change | TTM Jun 30, 2025 | TTM Jun 30, 2024 |
|---|---|---|---|---|---|
| Net profit attributable to owners (RMB mn) | 1,030 | 1,252 | -17.67% | - | - |
| Gross profit (RMB mn) | 7,576 | 8,048 | -5.85% | - | - |
| Net profit margin | 2.75% | 3.73% | -0.98ppt | - | - |
| EPS (RMB) | - | - | - | 0.129 | 0.157 |
| ROE (forecast, 3 years) | 7.5% | ||||
- Primary drivers: revenue mix shift toward lower-margin segments and reduced gross margins, weighing on net margins and EPS.
- Investor focus areas: margin recovery initiatives, product/service mix, and execution against the forecasted ROE improvement.
- Financial leverage and cash conversion trends will determine how quickly earnings can rebound given current margin pressure.
AviChina Industry & Technology Company Limited (2357.HK) - Debt vs. Equity Structure
AviChina's balance-sheet profile as of June 30, 2025 shows a sizable asset base with a roughly equal split between debt and equity funding, modestly increased leverage year‑on‑year, and a healthy liquidity cushion.| Metric | Amount | Notes / Calculation |
|---|---|---|
| Total assets | RMB 199.53 billion | As of 30 Jun 2025 |
| Total liabilities | RMB 101.79 billion | As of 30 Jun 2025 |
| Total equity | RMB 97.74 billion | As of 30 Jun 2025 |
| Debt-to-equity ratio | ~1.04 | Total liabilities ÷ Total equity (101.79 ÷ 97.74) |
| Gearing ratio | 9.62% | Up from 8.79% at FY2024-end |
| Cash & cash equivalents | RMB 30,390 million | Provides liquidity buffer |
| R&D expenses | RMB 2,170 million | +6.84% YoY investment in R&D |
| Market capitalization | HKD 31.65 billion | Market value at reporting point |
| Shares outstanding | 7.97 billion | Used to compute per‑share metrics |
| Equity per share (approx.) | RMB 12.26 | 97.74 bn ÷ 7.97 bn shares |
- Debt-to-equity ~1.04 indicates liabilities slightly exceed equity; capital structure is balanced but not conservatively low-levered.
- Gearing rising from 8.79% to 9.62% signals a modest increase in financial leverage; monitor trend for further rises.
- Cash balance (~RMB 30.39bn) covers a substantial portion of short-term obligations and supports capex/R&D spending.
- R&D spend (RMB 2.17bn, +6.84%) reflects reinvestment into product/technology development, important for defense/aerospace competitiveness.
- Market cap HKD 31.65bn vs. book equity RMB 97.74bn may imply market pricing differences driven by earnings outlook, sector sentiment, or FX considerations.
AviChina Industry & Technology Company Limited (2357.HK) - Liquidity and Solvency
Key liquidity and solvency observations for AviChina Industry & Technology Company Limited (2357.HK) for the first half of 2025, based on disclosed cash-flow and strategic information.
- Current ratio: not directly available from provided data.
- Quick ratio: not directly available from provided data.
- Cash ratio: not directly available from provided data.
| Metric | H1 2025 | Change vs H1 2024 | Notes |
|---|---|---|---|
| Net change in cash | RMB -4.48 billion | -11.87% | Negative cash change reflects operating, investing or financing outflows in H1 2025 |
| Free cash flow | RMB 662.02 million | +223.36% | Substantial improvement year-over-year in FCF for H1 2025 |
| Reported liquidity ratios | Not reported | N/A | Current/quick/cash ratios not directly available in provided figures |
- Implication of negative net cash change: despite improved FCF, overall cash decreased by RMB 4.48bn - signals material cash outflows (capex, M&A, debt repayment or financing activities) in H1 2025.
- Improved free cash flow (+223.36% YoY) suggests stronger operating cash generation or lower discretionary investment during the period, which can support servicing short-term obligations.
- Unavailable standard liquidity ratios (current, quick, cash) limit precise assessment of short-term solvency without access to the balance-sheet line items for current assets, inventory and current liabilities.
- Ongoing strategic focus on digital transformation and green aviation may require additional near-term investment (capex/R&D), affecting future liquidity and solvency trajectories.
- Potential balance considerations for investors:
- Monitor quarterly cash-flow statements for sources of the negative net cash change (operating vs investing vs financing).
- Watch for changes in working capital, capex guidance, and debt maturities that could stress liquidity.
- Seek full balance-sheet disclosure to compute current and quick ratios for a complete short-term solvency view.
Further context and investor-oriented details can be found here: Exploring AviChina Industry & Technology Company Limited Investor Profile: Who's Buying and Why?
AviChina Industry & Technology Company Limited (2357.HK) - Valuation Analysis
AviChina shows valuation characteristics consistent with a defensively priced industrial/aerospace name: low market multiples, modest dividend yield and low market volatility. Key headline metrics are presented below and contextualized for investor decision-making.| Metric | Value | Notes |
|---|---|---|
| TTM P/E | 14.28 | Trailing earnings basis |
| Forward P/E | 12.16 | Analyst consensus forward EPS |
| Price-to-Sales (P/S) | 0.31 | Revenue multiple - indicates low revenue-based valuation |
| Price-to-Book (P/B) | 0.29 | Below 1.0 - potential undervaluation vs. book value |
| Enterprise Value (EV) | RMB 83.26 billion | Incorporates debt and cash |
| Market Capitalization | RMB 30.70 billion | Equity value implied by price |
| Beta | 0.48 | Low historical volatility vs. market |
| Dividend Yield | 2.09% | Ex-dividend date: 22 May 2025 |
| Analyst Consensus | Hold | Price target: HK$5.00 |
- Valuation signal: P/S of 0.31 and P/B of 0.29 typically point to market-perceived undervaluation relative to peers or historical norms in capital-intensive sectors.
- Earnings trajectory: Forward P/E (12.16) below TTM P/E (14.28) implies analysts expect EPS improvement or a lower share price projection factored into consensus.
- Capital structure: EV ≈ RMB 83.26B vs. market cap ≈ RMB 30.70B suggests material net debt or minority interests included in EV - check balance sheet for leverage metrics.
- Volatility & defensive profile: Beta 0.48 indicates lower sensitivity to equity market swings, attractive to risk-averse investors seeking exposure to aerospace manufacturing without high beta.
- Income component: 2.09% dividend yield provides modest cash return; ex-dividend date 22 May 2025 important for dividend capture timing.
- Analyst view: Mixed - consensus is Hold with a price target of HK$5.00, signaling limited near-term upside per sell-side coverage.
- Practical investor checks:
- Compare P/B and P/S to domestic and global aerospace peers to assess relative undervaluation.
- Review recent earnings revisions - ensure forward P/E is driven by genuine earnings improvement rather than one-off items.
- Examine balance sheet detail (net debt, pension liabilities) to reconcile EV vs. market cap difference.
- Monitor dividend sustainability by checking payout ratio and free cash flow trends.
AviChina Industry & Technology Company Limited (2357.HK) - Risk Factors
AviChina's financial profile in the first half of 2025 shows several quantified warning signs that investors should weigh alongside strategic initiatives such as digital transformation and green aviation.- Net profit margin fell from 3.73% (H1 2024) to 2.75% (H1 2025), indicating compressed profitability and potential operational or pricing pressures.
- Gearing ratio increased from 8.79% to 9.62% over the same period, reflecting higher financial leverage and a modest rise in solvency risk.
- Net change in cash was RMB -4.48 billion in H1 2025, signaling significant cash outflows that may constrain short-term liquidity and working capital flexibility.
- Planned capital allocation toward digital transformation and green aviation initiatives will require substantial upfront investment, likely exerting continued pressure on margins and free cash flow before anticipated benefits materialize.
- Industry competition and demand cyclicality in the aviation sector pose risks to market share, contract pricing, and revenue growth trajectory.
- Regulatory shifts (safety, export controls, environmental standards, procurement rules) could impose compliance costs, delay programs, or restrict market access.
| Metric | H1 2025 | Context / Immediate Implication |
|---|---|---|
| Net Profit Margin | 2.75% | Down from 3.73% (H1 2024); margin compression requires either cost control or revenue mix improvement. |
| Gearing Ratio (Debt / Equity) | 9.62% | Up from 8.79% (H1 2024); incremental leverage increases interest and refinancing sensitivity. |
| Net Change in Cash | RMB -4.48 billion | Large negative cash movement in H1 2025; elevates short-term liquidity monitoring needs. |
- Operational levers to monitor: gross margin drivers by product/service line, working capital days, contract backlog conversion rates.
- Financial levers to monitor: short-term debt schedule, covenant thresholds, access to committed credit facilities, and planned CAPEX/phased investment schedules for digital/green projects.
- External levers to monitor: competitor wins/losses, tender pricing trends, regulator announcements, and macro demand indicators for aerospace and defense procurement.
AviChina Industry & Technology Company Limited (2357.HK) - Growth Opportunities
AviChina Industry & Technology Company Limited (2357.HK) is positioning itself to capture demand across aviation sub-sectors, with explicit strategic priorities that target near- and medium-term revenue expansion as well as longer-term value creation.- Low-altitude economy: management has signaled a focused push into low-altitude services and platforms (e.g., civil helicopters, UAS support, and air-ambulance/EMS markets) to tap growing domestic demand driven by urban air mobility and public-service applications.
- Helicopter competitiveness: product innovation combined with capacity expansion aims to raise market share in both government and commercial helicopter segments.
- Digital & green transformation: programs to digitize manufacturing and pursue greener propulsion/efficiency gains should reduce unit costs and open lifecycle-services and retrofit markets.
- Diversification into emerging industries: management plans to optimize the industrial structure, creating new revenue streams beyond core aero-platform sales (maintenance, training, avionics, software services).
- R&D investment: R&D expenditure rose by 6.84% to RMB 2,170 million, underscoring a commitment to product development and long-term competitiveness.
- Brand & governance modernization: strengthening brand value and upgrading governance frameworks to improve stakeholder confidence and access to capital/partners.
| Metric | Most Recent Figure | Change / Note |
|---|---|---|
| R&D expenses (RMB) | 2,170,000,000 | +6.84% year-on-year |
| Strategic focus areas | Low-altitude economy; Helicopters; Digital & Green | Operational expansion and product R&D |
| Expected new revenue channels | Maintenance, Training, Avionics, Software-as-a-Service | Industrial structure optimization |
- Investment implications for investors: rising R&D and targeted capacity expansion suggest potential margin recovery over time if product commercialization and service monetization succeed.
- Key execution risks: timely ramp-up of helicopter production, conversion of digital/green initiatives into profitable offerings, and competition in low-altitude services.

AviChina Industry & Technology Company Limited (2357.HK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.